Tenmizu FinTech

天良 4127

OTC · Biotechnology and medical care
Backtest

Sign up to add 天良 to your watchlist

Sign up to use the watchlist, price alerts and backtests, and keep your personalised settings.

Continue to sign up or sign in

Already have an account? Sign in

36.150 (0%)After close
Prev close
36.15
Volume (shares)
123,000
Data time
2026-11-11 13:30:00
Open
35.90
High
37.00
Low
35.05
Prev close
36.15
Volume (lots)
123
Turnover
0.04 億
P/E
88.2
Cash yield
—

Financial trends

Loading…

Consolidated statements; NT$100M (per-share items in NT$). Updated after each quarterly filing (MOPS). Some line items do not apply to financial companies.

Unit: 100 million TWD (EPS in TWD)Source: public data from MOPS, TWSE, TPEx and TDCC

Loading…

Figures are shown as announced, with no scoring or rating.

Metric2026 Q22026 Q12025 Q42025 Q32025 Q22025 Q12024 Q42024 Q3
Gross margin60.58%59.74%56.44%54.85%54.88%59.22%56.55%61.48%
Operating margin5.31%8.92%-18.66%2.00%-2.00%7.07%-6.03%2.38%
Net margin7.66%17.26%-2.02%17.16%-38.17%15.11%5.01%3.37%
ROE (TTM)14.25%1.27%-2.15%-0.68%-5.05%4.36%2.41%3.03%
ROA (TTM)6.06%0.56%-0.99%-0.32%-2.73%2.53%1.52%2.00%
EPS, quarter (TWD)0.310.75-0.050.51-1.070.390.100.07
EPS, TTM (TWD)1.520.14-0.22-0.07-0.510.480.260.32

MonthRevenueMoMYoYYTDYTD YoY
2026-100.4-22.60%2.33%6.040.66%
2026-090.64.02%10.94%5.544.98%
2026-080.5-7.05%40.83%5.050.27%
2026-070.66.27%25.19%4.451.53%
2026-060.6-8.45%41.38%3.856.60%
2026-050.6-11.89%27.02%3.359.51%
2026-040.73.02%66.79%2.769.33%
2026-030.7-14.41%47.08%2.070.23%
2026-020.845.42%139.06%1.383.44%
2026-010.521.51%37.07%0.537.07%
2025-120.4-0.75%74.97%5.134.82%
2025-110.43.15%35.04%4.731.98%

Revenue in NT$100M; 12 months per page.

Item2026 Q32026 Q22026 Q12025 Q42025 Q32025 Q22025 Q12024 Q4
Revenue1.71.82.01.31.41.31.20.9
Cost of revenue0.70.70.80.60.60.60.50.4
Gross profit1.01.11.20.70.70.70.70.5
Operating expenses0.91.01.01.00.70.70.60.5
Operating income0.10.10.2-0.20.0-0.00.1-0.1
Non-operating items-0.40.00.20.20.2-0.50.10.1
Pre-tax income-0.30.10.3-0.00.2-0.50.20.1
Income tax0.0-0.00.00.00.0-0.0-0.00.0
Continuing operations-0.30.10.3-0.00.2-0.50.20.0
Net income-0.30.10.3-0.00.2-0.50.20.0
Net income to parent-0.30.10.3-0.00.2-0.50.2—
Other comprehensive income0.10.0-0.0-0.00.00.00.0-0.0
Total comprehensive income-0.20.20.3-0.00.3-0.50.20.0
EPS (TWD)-0.590.310.75-0.050.51-1.070.390.10

Amounts in NT$100M (per-share items in NT$).

Item2026 Q32026 Q22026 Q12025 Q42025 Q32025 Q22025 Q12024 Q4
Current assets2.43.23.12.93.53.13.22.5
Non-current assets3.99.19.19.08.77.57.56.4
Total assets6.312.212.211.812.210.610.68.9
Current liabilities1.37.07.27.17.56.15.64.1
Non-current liabilities0.00.00.00.00.00.00.00.0
Total liabilities1.37.07.27.17.56.15.74.1
Share capital4.64.64.64.64.64.64.64.6
Capital surplus—0.00.00.00.00.00.00.0
Retained earnings0.40.70.60.20.30.00.50.3
Other equity0.0-0.1-0.1-0.1-0.0-0.1-0.1-0.1
Treasury stock——————0.00.0
Equity to parent5.05.25.04.74.84.55.0—
Total equity5.05.25.04.74.84.55.04.8
Book value per share (TWD)10.9811.3511.0010.3610.459.8410.8810.44

Amounts in NT$100M (per-share items in NT$).

Item2026 Q32026 Q22026 Q12025 Q42025 Q32025 Q22025 Q12024 Q4
Operating cash flow0.40.30.2-0.10.1-0.00.20.3
Investing cash flow4.7-0.30.30.1-1.0-0.6-1.3-1.1
Financing cash flow-5.6-0.0-0.0-0.71.30.71.20.7
Net change in cash-0.5-0.00.5-0.70.30.10.2-0.1
Cash, beginning1.21.21.21.31.31.31.31.4
Cash, ending1.11.71.71.22.01.61.51.3

Amounts in NT$100M (per-share items in NT$).

Metric2026 Q22026 Q12025 Q42025 Q32025 Q22025 Q12024 Q42024 Q3
Current ratio44.86%———————
Debt ratio57.56%58.74%59.94%60.91%57.36%53.22%46.22%39.44%
Equity ratio42.44%41.26%40.06%39.09%42.64%46.78%53.78%60.56%
Equity multiplier2.362.422.502.562.352.141.861.65

Metric2026 Q22026 Q12025 Q42025 Q32025 Q22025 Q12024 Q42024 Q3
Asset turnover (TTM revenue / avg. assets)0.570.520.490.460.500.450.500.57
Equity turnover1.341.191.080.980.930.770.790.86

Source: MOPS. For reference only; not investment advice.